The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety study of a novel alpha-fetoprotein (AFP)-maytansine conjugate in an ovarian xenograft model.
 
Igor A. Sherman
Employment - Alpha Cancer Technologies
Leadership - Alpha Cancer Technologies
Stock and Other Ownership Interests - Alpha Cancer Technologies
Honoraria - Alpha Cancer Technologies
Research Funding - Alpha Cancer Technologies
Patents, Royalties, Other Intellectual Property - Alpha Cancer Technologies
 
Wendy Hill
Employment - Alpha Cancer Technologies
Stock and Other Ownership Interests - Alpha Cancer Technologies
Consulting or Advisory Role - Alpha Cancer Technologies
Speakers' Bureau - Alpha Cancer Technologies
 
Patricia Griffin
Employment - Alpha Cancer Technologies
Stock and Other Ownership Interests - Alpha Cancer Technologies
Consulting or Advisory Role - Alpha Cancer Technologies
 
David Andrews
Research Funding - Amylyx; Genesis Biotechnology Group; Novartis Institutes for BioMedical Research; Redesign Science; Sanofi; Sanofi (I)
(OPTIONAL) Uncompensated Relationships - Prosetta Biosciences
 
Rebecca J Boohaker
No Relationships to Disclose
 
Karr Stinson
No Relationships to Disclose
 
Lilian Tran Gien
Consulting or Advisory Role - Corcept Therapeutics; GlaxoSmithKline Canada; Jazz Pharmaceuticals; Merck
 
Alla Buzina
No Relationships to Disclose
 
Wiebke Schormann
No Relationships to Disclose